Numerous studies have indicated that the mitogen-activated protein kinase (MAPK) signaling pathway plays an important role in regulating cell proliferation, promoting cell cycle progression [19–21], and inducing resistance to radiotherapy and chemotherapy in tumor cells [22, 23]. Here, WNK2 is linked to neoplasm.